OTTAWA, ONTARIO -- Kinaxis Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, announced that Dr. Wolff Group, a family-owned German manufacturer of cosmetic and pharmaceutical products, is working with Kinaxis, along with mSE Solutions, an expert supply chain optimization consultancy, to help drive faster and more accurate decision-making in supply chain planning and thus ensure a better balance between market and supply chain dynamics.

A growing company that exports its popular brands including Alpecin, Alcina, and Plantur among others, to more than 60 countries worldwide, Dr. Wolff faced challenges in managing its complex and diverse product portfolio that includes everything from hair care and styling products, to decorative cosmetics, dental care, and vaginal and dermatologic pharmaceuticals. In order to be able to react even more flexibly, quickly and efficiently to customer requirements, the company turned to mSE Solutions and Kinaxis to strengthen its supply chain processes.

By bringing together the strengths of their expert teams, Kinaxis and mSE Solutions will help Dr. Wolff Group in the end-to-end orchestration of the global supply chain by implementing Kinaxis' AI-powered platform.

“The diversity of our products and expansion into new markets make our supply chain particularly complex and challenging,” said Dr. Andreas Brinkhoff, Managing Director at Dr. Wolff Group. “mSE Solutions helped to identify the areas of our business that would benefit the most from supply chain orchestration technologies and by partnering with Kinaxis, we are developing a comprehensive view of our supply chain performance and risks across our entire end-to-end network. We are now prepared to respond to any disruptions.”

“Marked by hyper-competition, high volumes, and a frenetic pace, the consumer-packaged goods industry operates with a constant need for supply chain agility and efficiency,” said Martin Bilstein, regional vice president, DACH region at Kinaxis. “We’re thrilled to be part of the supply chain evolution that Dr. Wolff Group is undertaking and looking forward to supporting their success.”